1. Home
  2. DLPN vs EDSA Comparison

DLPN vs EDSA Comparison

Compare DLPN & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

HOLD

Current Price

$1.51

Market Cap

17.8M

ML Signal

HOLD

Logo Edesa Biotech Inc.

EDSA

Edesa Biotech Inc.

N/A

Current Price

$1.50

Market Cap

12.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DLPN
EDSA
Founded
1996
2015
Country
United States
Canada
Employees
269
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.8M
12.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DLPN
EDSA
Price
$1.51
$1.50
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
35.8K
32.3K
Earning Date
11-12-2025
12-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$53,371,115.00
N/A
Revenue This Year
$10.62
N/A
Revenue Next Year
$13.78
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.86
N/A
52 Week Low
$0.75
$1.44
52 Week High
$1.88
$4.49

Technical Indicators

Market Signals
Indicator
DLPN
EDSA
Relative Strength Index (RSI) 39.42 30.99
Support Level $1.44 $1.44
Resistance Level $1.65 $1.54
Average True Range (ATR) 0.09 0.08
MACD -0.02 -0.01
Stochastic Oscillator 18.18 9.03

Price Performance

Historical Comparison
DLPN
EDSA

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Share on Social Networks: